Oncology & Cancer

'Patchwork' tumors prevalent across multiple cancer types

Researchers at the Francis Crick Institute, as part of an international collaboration of scientists through the Pan-Cancer Analysis of Whole Genomes Consortium, have analyzed the whole genomes of tumor samples from over 2,600 ...

Medical research

Research uncovers additional treatment option in prostate cancer

The standard treatment for advanced metastatic prostate cancer (PCa) is androgen deprivation therapy (ADT). And even if this is efficient in the short term, 1/3 of PCa will become resistant to ADT and develop castration-resistant ...

Oncology & Cancer

'Catch-22' scenario good news for some cancer patients

Traits that allow cancer cells to escape the body's natural defense system and develop into tumors are actually a good indicator to a patient's survival prognosis, according to University of Queensland researchers.

Oncology & Cancer

Detonating fuse for breast cancer discovered

Breast cancer is the most common type of tumor found in women. Each year in Germany alone, 69,000 new cases are diagnosed. Around 80 percent of tumors originate in the luminal cells, the milk-producing cells of the mammary ...

Oncology & Cancer

A leap forward in research on CAR T cell therapy

In cancer immunotherapy, cells in the patient's own immune system are activated to attack cancer cells. CAR T cell therapy has been one of the most significant recent advances in immunotherapies targeted at cancer.

Oncology & Cancer

Cancer: A new killer lymphocyte enters the ring

Treatments for beating tumors are mainly based on CD8 T lymphocytes, which specialize in detecting and eliminating intracellular infections and in killing cancer cells. A large proportion of patients, however, do not respond ...

page 6 from 40